Bridgeworth’s Accenture ACN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$1.98M Sell
5,657
-50
-0.9% -$16.1K 0.2% 49
2023
Q3
$1.75M Buy
5,707
+1,070
+23% +$337K 0.19% 48
2023
Q2
$1.43M Sell
4,637
-219
-5% -$63.6K 0.16% 60
2023
Q1
$1.39M Sell
4,856
-23
-0.5% -$6.27K 0.18% 60
2022
Q4
$1.3M Buy
4,879
+6
+0.1% +$1.66K 0.21% 61
2022
Q3
$1.25M Sell
4,873
-137
-3% -$39.6K 0.29% 54
2022
Q2
$1.39M Buy
5,010
+1,984
+66% +$596K 0.33% 52
2022
Q1
$1.02M Sell
3,026
-386
-11% -$130K 0.23% 61
2021
Q4
$1.42M Sell
3,412
-110
-3% -$40.1K 0.31% 45
2021
Q3
$1.13M Buy
3,522
+1,905
+118% +$620K 0.32% 49
2021
Q2
$477K Buy
1,617
+46
+3% +$13.2K 0.14% 76
2021
Q1
$434K Buy
1,571
+2
+0.1% +$517 0.14% 75
2020
Q4
$410K Buy
1,569
+356
+29% +$85.3K 0.14% 76
2020
Q3
$274K Buy
1,213
+1
+0.1% +$229 0.1% 97
2020
Q2
$260K Buy
+1,212
New +$229K 0.1% 98
2020
Q1
Sell
-1,227
Closed -$258K 122
2019
Q4
$258K Buy
1,227
+2
+0.2% +$390 0.1% 109
2019
Q3
$236K Hold
1,225
0.09% 112
2019
Q2
$226K Buy
+1,225
New +$220K 0.09% 117
2018
Q3
Sell
-608
Closed -$99K 137
2018
Q2
$99K Buy
+608
New +$94.6K 0.04% 197

Other funds holding ACN

Bridgeworth's ACN Position: Q4 2023 in Review

Bridgeworth reduced its Accenture (ACN) stake by 0.88% in Q4 2023, selling an estimated $16.1K and leaving 5,657 shares worth $1.98M. The position accounts for 0.2% of the portfolio, ranked #49.

Bridgeworth first reported a position in ACN in Q2 2018 and has held it in 19 quarters since. 2,311 funds tracked by Wall St. Rank hold ACN as of Q4 2023.

  • Bridgeworth held 5,657 shares of Accenture worth $1.98M as of Q4 2023.
  • Bridgeworth sold 50 Accenture shares in Q4 2023, an estimated $16.1K.
  • Accenture made up 0.2% of Bridgeworth's portfolio in Q4 2023, its #49 holding.
  • Bridgeworth first reported a position in Accenture in Q2 2018 and has held it in 19 quarters since.
  • 2,311 funds tracked by Wall St. Rank held Accenture as of Q4 2023.

Based on Bridgeworth's 13F filing for Q4 2023, filed 26 Jan 2024.